What is NDC 71610-229?

71610-229 is the product NDC for Lorazepam, Lorazepam 1 mg/1 tablet, listed with the FDA by Aphena Pharma Solutions - Tennessee, LLC. It has 10 package NDCs, shown above in 10- and 11-digit form.

Aphena Pharma Solutions - Tennessee, LLC, NDC labeler code 71610. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Lorazepam?

135 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Lorazepam NDC 71610-229 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)71610-229Labeler and product segments. Claims need a package NDC.

Product NDC at billing width71610-0229Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
71610-229-10	71610022910	10 TABLET in 1 BOTTLE (71610-229-10)Marketed from Oct 12, 2023
71610-229-15	71610022915	15 TABLET in 1 BOTTLE (71610-229-15)Marketed from Feb 1, 2019
71610-229-30	71610022930	30 TABLET in 1 BOTTLE (71610-229-30)Marketed from Feb 1, 2019
71610-229-45	71610022945	45 TABLET in 1 BOTTLE (71610-229-45)Marketed from Feb 1, 2019
71610-229-53	71610022953	60 TABLET in 1 BOTTLE (71610-229-53)Marketed from Feb 1, 2019
71610-229-55	71610022955	75 TABLET in 1 BOTTLE (71610-229-55)Marketed from Feb 1, 2019
71610-229-60	71610022960	90 TABLET in 1 BOTTLE (71610-229-60)Marketed from Feb 1, 2019
71610-229-70	71610022970	120 TABLET in 1 BOTTLE (71610-229-70)Marketed from Feb 1, 2019
71610-229-75	71610022975	150 TABLET in 1 BOTTLE (71610-229-75)Marketed from Feb 1, 2019
71610-229-80	71610022980	180 TABLET in 1 BOTTLE (71610-229-80)Marketed from Feb 1, 2019

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Lorazepam
Generic name (nonproprietary): lorazepam
Active ingredients: Lorazepam — 1 mg/1
Dosage form: Tablet
Route: Oral
Labeler: Aphena Pharma Solutions - Tennessee, LLCNDC labeler code 71610
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 203572
Marketing start: Mar 24, 2017
Listing expires: Dec 31, 2026
DEA schedule: CIV
Other FDA classes: Benzodiazepines (Chemical structure)
Identifiers: Product ID 71610-229_e2bf4a43-faf3-433b-8f77-8d5d03600845SPL ID e2bf4a43-faf3-433b-8f77-8d5d03600845SPL set ID 247110f2-5468-4593-8d86-41f8c869e03dRxCUI 197901UNII O26FZP769L
Pharmacologic class: Benzodiazepine

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N471610022910 followed by a unit qualifier and the quantity

Package 71610-0229-10. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Oct 17, 2023. This label includes a boxed warning.

Indications (excerpt from the label)

INDICATIONS AND USAGE Lorazepam tablets are indicated for the management of anxiety disorders or for the short-term relief of the symptoms of anxiety or anxiety associated with depressive symptoms. Anxiety or tension associated with the stress of everyday life usually does not require treatment with an anxiolytic. The effectiveness of lorazepam tablets in long-term use, that is, more than 4 months, has not been assessed by systematic clinical studies. The physician should periodically reassess the usefulness of the drug for the individual patient.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 71610-229

What is NDC 71610-229?: 71610-229 is the product NDC for Lorazepam, Lorazepam 1 mg/1 tablet, listed with the FDA by Aphena Pharma Solutions - Tennessee, LLC. It has 10 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Lorazepam.
What is the active ingredient?: Lorazepam.
Who is the labeler?: Aphena Pharma Solutions - Tennessee, LLC, NDC labeler code 71610. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Lorazepam?: 135 other product NDCs are listed under this name. See all Lorazepam NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Lorazepam NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Lorazepam	Lorazepam 1 mg/1	TabletOral	Unit Dose Solutions, Inc.	87441-091	87441-0091-01
Lorazepam	Lorazepam 1 mg/1	TabletOral	Preferred Pharmaceuticals Inc.	68788-4180	68788-4180-0168788-4180-0368788-4180-06+2 more
Lorazepam	Lorazepam 1 mg/1	TabletOral	St. Mary's Medical Park Pharmacy	60760-948	60760-0948-02
Lorazepam	Lorazepam .5 mg/1	TabletOral	St. Mary's Medical Park Pharmacy	60760-947	60760-0947-02
Lorazepam	Lorazepam .5 mg/1	TabletOral	Unit Dose Solutions, Inc.	87441-050	87441-0050-01
Lorazepam	Lorazepam 2 mg/1	TabletOral	Unit Dose Solutions, Inc.	87441-051	87441-0051-01
Lorazepam	Lorazepam 1 mg/1	TabletOral	Coupler LLC	67046-0230	67046-0230-03
Lorazepam	Lorazepam .5 mg/1	TabletOral	Coupler LLC	67046-0786	67046-0786-03
Lorazepam	Lorazepam 2 mg/1	TabletOral	Coupler LLC	67046-0936	67046-0936-03
Lorazepam	Lorazepam 2 mg/mL	LiquidOral	American Health Packaging	68000-107	68000-0107-05

All 136 Lorazepam NDCs

Other NDCs under ANDA 203572

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 203572
Product	Strength	Form · route	Labeler	Product NDC
Lorazepam	Lorazepam 1 mg/1	TabletOral	Preferred Pharmaceuticals Inc.	68788-4180
Lorazepam	Lorazepam 1 mg/1	TabletOral	NuCare Pharmaceuticals,Inc.	68071-5022
Lorazepam	Lorazepam .5 mg/1	TabletOral	NuCare Pharmaceuticals,Inc.	68071-5068
Lorazepam	Lorazepam 1 mg/1	TabletOral	Advanced Rx of Tennessee, LLC	80425-0465
Lorazepam	Lorazepam .5 mg/1	TabletOral	American Health Packaging	60687-820
Lorazepam	Lorazepam 1 mg/1	TabletOral	American Health Packaging	60687-831
Lorazepam	Lorazepam 2 mg/1	TabletOral	American Health Packaging	60687-842
Lorazepam	Lorazepam .5 mg/1	TabletOral	Bryant Ranch Prepack	71335-1455
Lorazepam	Lorazepam 1 mg/1	TabletOral	REMEDYREPACK INC.	70518-3870
Lorazepam	Lorazepam 2 mg/1	TabletOral	PD-Rx Pharmaceuticals, Inc.	72789-339
Lorazepam	Lorazepam .5 mg/1	TabletOral	Preferred Pharmaceuticals Inc.	68788-7355
Lorazepam	Lorazepam 1 mg/1	TabletOral	Preferred Pharmaceuticals, Inc.	68788-7428
Lorazepam	Lorazepam 2 mg/1	TabletOral	Aphena Pharma Solutions - Tennessee, LLC	71610-600
Lorazepam	Lorazepam 1 mg/1	TabletOral	NuCare Pharmaceuticals,Inc.	68071-5250
Lorazepam	Lorazepam 2 mg/1	TabletOral	Preferred Pharmaceuticals, Inc.	68788-7533
Lorazepam	Lorazepam .5 mg/1	TabletOral	Aphena Pharma Solutions - Tennessee, LLC	71610-199
Lorazepam	Lorazepam 1 mg/1	TabletOral	A-S Medication Solutions	50090-5563
Lorazepam	Lorazepam 2 mg/1	TabletOral	Bryant Ranch Prepack	71335-1138
Lorazepam	Lorazepam 1 mg/1	TabletOral	A-S Medication Solutions	50090-5562
Lorazepam	Lorazepam .5 mg/1	TabletOral	Aurolife Pharma LLC	13107-083

Showing 20 of 27.